Jing Yang

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Mesenchymal Stem Cells

Combination Therapy

Top Venues

Hepatology communications

Journal of clinical and translational hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Hengfen Dai, Jing Yang
Development and Validation of a Clinical Risk Score to Predict Immune-mediated Liver Injury Caused by Sintilimab: Assessed for Causality Using Updated RUCAM. Journal of clinical and translational hepatology 11 (6) (2023)
Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Ruping Ni, Hengfen Dai, Xiuqin Lin, Jing Yang
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known. Hepatology communications 7 (3) (2023)
Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Ruping Ni, Hengfen Dai, Xiuqin Lin, Jing Yang
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known. Hepatology communications 7 (3) (2023)
Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Ruping Ni, Hengfen Dai, Xiuqin Lin, Jing Yang
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known. Hepatology communications 7 (3) (2023)
Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Ruping Ni, Hengfen Dai, Xiuqin Lin, Jing Yang
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known. Hepatology communications 7 (3) (2023)
Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Ruping Ni, Hengfen Dai, Xiuqin Lin, Jing Yang
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known. Hepatology communications 7 (3) (2023)